Acute brucellosis complicated by fatal myocarditis  by Pandit, Vinay Ramakrishna et al.
International Journal of Infectious Diseases 14 (2010) e358–e360Letter to the Editor
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
journa l homepage: www.e lsev ier .com/ locate / i j idAcute brucellosis complicated by fatal myocarditis
Cardiac complications, especially myocarditis, are very rare in
brucellosis.1,2 Only a few cases of primary myocarditis in adults
have been reported.2–4We report herein a case of acute brucellosis
complicated by severe myocarditis resulting in death.
A 32-year-old woman, housewife by occupation, was admitted
for evaluation of fever of 20 days duration, which was moderate
grade and associated with chills, evening rise, and intense
sweating. She had vomiting and loose stools for two days before
hospitalization. She had also noticed a loss of appetite and
signiﬁcant weight loss. There was no history of close contact with
animals or consumption of raw milk. She was treated with a short
course of antibiotics before hospitalization. She was a known
asthmatic from childhood, which was under control with
bronchodilators. Physical examination revealed a pulse rate of
100/min, blood pressure of 130/80 mmHg, respiratory rate of 20/
min, high spikes of fever, moderate pallor, and small, insigniﬁcant
cervical lymphadenopathy. On examination, her abdomenwas soft
with tender hepatomegaly of 3 cm below the right costal margin.
Respiratory examination revealed bilateral rhonchi. Cardiac
examination was normal. At the time of admission, hematological
investigations showed hemoglobin of 10.2 g/dl, a total leukocyte
count of 5.5  109 cells/l (with differential count of 79%
neutrophils, 19% lymphocytes, 2% eosinophils), platelets of
120  109/l, and erythrocyte sedimentation rate of 104 mm/h.
Metabolic parameters were as follows: blood urea 17 mg/dl, serum
creatinine 0.9 mg/dl, sodium 124 mEq/dl, and potassium 4.2 mEq/
dl; liver function tests revealed total bilirubin 1.7 mg/dl, direct
bilirubin 0.9 mg/dl, SGOT 285 U/l, SGPT 196 U/l, alkaline
phosphatase 246 U/l, and total protein 6.9 g/dl, with albumin
3.3 g/dl and globulin 3.6 g/dl. Serum calcium, magnesium, and
phosphorus were normal. Thyroid function tests and serum
cortisol levels were normal. HIV ELISA, the tuberculin skin test,
and the Widal test were all negative. An initial chest X-ray was
normal and echocardiographywas normal with ejection fraction of
63%, without any left ventricular dysfunction. Ultrasound exam-
ination of the abdomen revealed mild hepatomegaly. Electro-
cardiography showed sinus tachycardia. The Brucella
agglutination titer was strongly positive (>1:1280) by standard
tube agglutination test. Three blood cultures were performed on
the day of admission by BacT/Alert automated system. All the
cultures isolated Brucella species on the fourth day of incubation.
However a bone marrow culture was sterile even after 20 days of
incubation. A bone marrow biopsy showed reactive cellular
marrow with hemophagocytosis and granulomatous inﬂamma-
tion, and staining for acid-fast bacilli was negative. Initially she
was started on treatment with streptomycin and doxycycline.
Rifampin was not given in view of the deranged liver function. On
the fourth day of hospitalization she deteriorated and developed
severe tachypnea. Examination of the chest revealed bilateral1201-9712/$36.00 – see front matter  2009 International Society for Infectious Disea
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edema (Figure 1). Echocardiography was repeated and showed
global hypokinesia, severe left ventricular dysfunction, andmild to
moderate mitral regurgitation with ejection fraction of 27%,
suggestive of myocarditis, without any vegetation (Figures 2
and 3). Serum creatine kinase (CK) was 430 IU and CK-MB was 78
IU. Troponin T was positive 0.43 (normal range 0.001–0.03 units).
She developed hypotensionwhichwas refractory to a combination
of ionotropic supports and succumbed to the illness over a period
of three days.
Brucellosis is an anthropozoonosis with a polymorphic, world-
wide distribution, presenting with protean manifestations. The
disease is endemic in countries of the Mediterranean basin,
Arabian Gulf, Indian subcontinent, and parts of Mexico and South
America. Worldwide, the reported incidence of human brucellosis
in endemic disease areas varies widely, from <0.01 to >200 per
100 000 population.5 Complications of brucellosis can be very
diverse depending on the speciﬁc site of infection – osteoarticular,
genitourinary, gastrointestinal, nervous system, cardiovascular,
skin and mucous membranes, and respiratory system.
Most often myocarditis results from common viral infections,
occurring less commonly as a result of other bacterial or parasitic
pathogens.6 Cardiac involvement in brucellosis is extremely rare,
ranging from 0% to 2%. The most common cardiac complication is
endocarditis, usually involving the aortic valve.1 Other rarely
reported cardiac complications are pericarditis and myocarditis.
Cardiac involvement might occur as a part of disseminated disease
with other organ involvement or as an isolated manifestation.
Isolated pericardial or myocardial involvement is exceptional.2
Myocarditis is an uncommon complication of brucellosis in the
absence of endocarditis. Acute brucellosis complicated primarily
bymyocarditis, without other organ involvement is rare. In spite of
early diagnosis and initiation of aggressive treatment, the outcome
was fatal.
The frequency of cardiac involvement in published case series
of brucellosis is very low. In a study of 530 cases, Colmenero et al.7
reported that cardiac involvement was seen in less than 2% of
cases; Lulu et al.,8 in prospective study of 400 cases, described two
cases of endocarditis and one case of myocarditis; Kochar et al.,9 in
a prospective study of 175 cases, described one case of
endocarditis. Few descriptive data are available for Brucella
pericarditis and even fewer for Brucella myocarditis. Lubani
et al.10 reported three cases of myocarditis in a series of 200
children with brucellosis. Khorvash et al.11 described the
occurrence of myocarditis as a part of disseminated brucellosis
along with neurologic, renal, and liver involvement with low
agglutination titers. The occurrence of isolated myocarditis has
been reported by only a few authors: Jubber et al.4 described
pulmonary edema and interstitial pneumonia due to Brucella
myocarditis, which was treated successfully; Villaverde et al.3
described the ﬁrst reported case ofmyocarditis fromArgentina andses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Chest X-ray showing features of early pulmonary edema.
Figure 3. Color Doppler showing left ventricular dysfunction with mitral
regurgitation.
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knowledge this is the ﬁrst case of myocarditis being reported from
India.
The diagnosis of brucellosis requires the isolation of organ-
isms from blood and/or body tissues, or the combination of
suggestive clinical presentation and positive serology. In most
centers, the standard agglutination test is still the mainstay of
serological diagnosis of brucellosis. In an endemic setting, >90%
of patients with acute bacteremia have titers of at least 1:320.
The gold standard for the diagnosis is isolation of Brucella from
blood, cerebrospinal ﬂuid, bone marrow, or from a tissue sample,
but diagnostic yield varies from 15% to 90%.12–15 The diagnostic
yield of cultures has been greatly enhanced by the use of modern
automated blood culture systems, simultaneously reducing time
to positivity. The number of positive results is usually greater in
acute brucellosis; however this ﬁgure is notably reduced in cases
of focal complications and chronic illness.12 In most of the cases,
myocarditis is an echocardiographic diagnosis with elevated
levels of creatine phosphokinase (CPK-MB) and positive troponin
T levels. In this case, echocardiography was done at the time of
admission (which was normal) and three blood cultures wereFigure 2. 2-D echocardiography showing severe global hypokinesia and left
ventricular dysfunction.sent considering infective endocarditis as one of the differential
diagnoses. All three cultures isolated the organism in less than a
week, however bone marrow cultures were sterile. The cardiac
damage might be due to the direct effect of the microorganism or
to the local deposition of immune complexes. Rapid worsening
should alert the treating physicians regarding pulmonary edema
due to myocarditis or cardiac tamponade. There is paucity of data
regarding the prognosis for Brucella myocarditis. A favorable
outcome has been described by a few authors, even in the
presence of heart failure.3 Pericardial involvement remains
asymptomatic, however rarely can cause tamponade.2 In the
presence of endocarditis at least three drugs (an aminoglycoside,
a tetracycline, and rifampin) are given for a minimum 6 months
and surgical treatment may be required in a good number of
cases.1
Even in endemic areas, brucellosis remains a diagnostic puzzle;
typical history of close animal contact or occupational exposure
may not be available and atypical presentations are not unusual.
The possibility of brucellosis, with its impending complications,
has to be considered in all cases of prolonged fever. Early diagnosis,
prompt recognition of complications, and aggressive treatment is
essential to reduce the mortality.
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